A Clinical Study of SHP674 in Patients With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia
Phase 2
- Conditions
- Acute Lymphoblastic Leukemia
- Registration Number
- JPRN-UMIN000042023
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
Mature B-cell ALL ; Philadelphia chromosome-positive (Ph+) or BCR-ABL1-positive ALL. Preexisting known coagulopathy. History of pancreatitis. Continuous use of corticosteroids. Prior treatment or possible prior treatment with an L-asparaginase preparation. History of sensitivity to polyethylene glycol (PEG) or PEG-based drugs. Pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method